共 50 条
- [21] COLLAGENASE CLOSTRIDIUM HISTOLYTICUM FOR THE TREATMENT OF PEYRONIE'S DISEASE - A SINGLE CENTRE EXPERIENCE JOURNAL OF SEXUAL MEDICINE, 2023, 20 : 63 - 63
- [22] INCIDENCE OF SECONDARY INTERVENTION FOR PEYRONIE'S DISEASE AFTER COLLAGENASE CLOSTRIDIUM HISTOLYTICUM JOURNAL OF SEXUAL MEDICINE, 2022, 19 (04): : S36 - S36
- [23] PEYRONIE'S DISEASE: THE IMPACT OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM ON DIAGNOSIS, TREATMENT, AND COST JOURNAL OF UROLOGY, 2018, 199 (04): : E883 - E883
- [24] REASONS OF DISCONTINUATION FROM COLLAGENASE CLOSTRIDIUM HISTOLYTICUM TREATMENTS IN PEYRONIE'S DISEASE JOURNAL OF SEXUAL MEDICINE, 2023, 20
- [25] An illustrated description of a modified collagenase Clostridium histolyticum protocol for Peyronie's disease JOURNAL OF SEXUAL MEDICINE, 2024, 21 (12): : 1169 - 1177
- [26] Collagenase Clostridium histolyticum in the treatment of Peyronie's disease: patient selection and perspectives PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 431 - 448
- [28] Re: Management of Peyronie's Disease with Collagenase Clostridium Histolyticum in the Acute Phase JOURNAL OF UROLOGY, 2021, 205 (01): : 289 - 289
- [29] COLLAGENASE CLOSTRIDIUM HISTOLYTICUM IN PEYRONIE'S DISEASE: INTRODUCTION OF THIS NOVEL TREATMENT IN THE NETHERLANDS JOURNAL OF SEXUAL MEDICINE, 2020, 17 (06): : S181 - S182
- [30] PEYRONIE'S DISEASE - OUTCOMES OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM INJECTION: A SYSTEMATIC REVIEW JOURNAL OF SEXUAL MEDICINE, 2022, 19 (05): : S219 - S220